Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.31 |
| ▸ | FDPS | P14324 | 10/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8469558 | 0.72 | GGPS1 (0.33) | SMPD1FDPSGGPS1 | |
| SCHEMBL11213046 | 0.71 | GGPS1 (0.41) | SMPD1FDPSGGPS1 | |
| SCHEMBL10794238 | 0.67 | SMPD1 (0.41) | SMPD1FDPSGGPS1 | |
| SCHEMBL918183 | 0.67 | SMPD1 (0.41) | SMPD1FDPSGGPS1 | |
| SCHEMBL3685062 | 0.66 | FDPS (0.31) | FDPS | |
| SCHEMBL11503181 | 0.66 | SMPD1 (0.34) | SMPD1FDPS | |
| SCHEMBL5861642 | 0.66 | LMNA (0.46) | SMPD1FDPSGGPS1 | |
| SCHEMBL142411 | 0.65 | FDPS (0.33) | FDPS | |
| SCHEMBL3820203 | 0.63 | CES2 (0.39) | — | |
| SCHEMBL10799271 | 0.62 | LMNA (0.41) | SMPD1FDPSGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2609068-B1 | PROCESSES FOR THE PRODUCTION OF ESTERS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2020-03-18 | — | — | EP | disclosed |
| US-9725401-B2 | Processes for the production of esters | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-20140343204-A1 | Esters, Hydrogenated Derivatives Thereof, and Processes for Producing the Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-11-20 | — | — | US | disclosed |
| US-20140148612-A1 | Processes for the Production of Esters | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-05-29 | — | — | US | disclosed |
| EP-2609068-A1 | PROCESSES FOR THE PRODUCTION OF ESTERS | ExxonMobil Chemical Patents Inc. (US) | 2013-07-03 | — | — | EP | disclosed |
| WO-2013025277-A1 | ESTERS AND THEIR PREPARATION AND USE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-02-21 | — | — | WO | disclosed |
| US-8344174-B2 | Batch esterification | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-01-01 | — | — | US | disclosed |
| WO-2012025308-A1 | PROCESSES FOR THE PRODUCTION OF ESTERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-01 | — | — | WO | disclosed |
| US-20110313090-A1 | Method For The Manufacture Of Long Chain Phthalate Dialkyl Ester Compositions | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-12-22 | — | — | US | disclosed |
| EP-2352716-A1 | IMPROVED METHOD FOR THE MANUFACTURE OF LONG CHAIN PHTHALATE DIALKYL ESTER COMPOSITIONS | ExxonMobil Chemical Patents Inc. (US) | 2011-08-10 | — | — | EP | disclosed |
| EP-2121560-B1 | BATCH ESTERIFICATION | EXXONMOBIL CHEM PATENTS INC (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100137631-A1 | BATCH ESTERIFICATION | EXXONMOBIL CHEMICAL PATENTS INC. | 2010-06-03 | — | — | US | disclosed |
| WO-2010057847-A1 | IMPROVED METHOD FOR THE MANUFACTURE OF LONG CHAIN PHTHALATE DIALKYL ESTER COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2010-05-27 | — | — | WO | disclosed |
| EP-2121560-A1 | BATCH ESTERIFICATION | ExxonMobil Chemical Patents Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008110306-A1 | BATCH ESTERIFICATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343204-A1 | Esters, Hydrogenated Derivatives Thereof, and Processes for Producing the Same | ADH5, HDHD5, ADH1A | SMPD1 2575/4885FDPS 85/4885GGPS1 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.